Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
7,76 CNY | +2,37% |
|
-2,14% | -29,84% |
Attività
Numero di dipendenti: 1 962
Vendite per attività
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Crack, Small Crack
61,1
%
| 728 | 58,6 % | 738 | 61,1 % | +1,38% |
Other Pharmaceutical Products
16,6
%
| 180 | 14,5 % | 201 | 16,6 % | +11,83% |
OEM and Wholesale and Retail Pharmaceuticals
8,6
%
| 152 | 12,3 % | 104 | 8,6 % | -31,50% |
Complete Production Line
6,4
%
| 98 | 7,9 % | 78 | 6,4 % | -20,60% |
Health Product
3,5
%
| 27 | 2,1 % | 42 | 3,5 % | +60,27% |
Real Estate Leasing and Management
3,2
%
| 42 | 3,4 % | 38 | 3,2 % | -9,05% |
Mechanical Parts and Others
0,6
%
| 11 | 0,9 % | 7 | 0,6 % | -34,27% |
Vendite per regione
CNY in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
99,6
%
| 1 231 | 99,1 % | 1 205 | 99,6 % | -2,12% |
Overseas
0,4
%
| 12 | 0,9 % | 4 | 0,4 % | -62,02% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 09/12/19 |
Qing Guo Wang
DFI | Director of Finance/CFO | 49 | 25/08/22 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 13/10/17 |
Qiang Lin
BRD | Director/Board Member | 60 | 01/07/04 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 01/07/04 |
Xin He
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jin Lou
BRD | Director/Board Member | 94 | 13/10/17 |
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 09/12/19 |
Yi Xi Kuai
BRD | Director/Board Member | 66 | 01/07/04 |
Qiang Lin
BRD | Director/Board Member | 60 | 01/07/04 |
Run Xiu Li
BRD | Director/Board Member | 55 | 01/07/04 |
Jian Wei Zhu
BRD | Director/Board Member | 69 | 18/11/20 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 13/10/17 |
Wen Jie Ma
BRD | Director/Board Member | 42 | 13/10/17 |
Xiao Xia Sheng
BRD | Director/Board Member | 47 | 18/11/20 |
Jian Quan Miao
BRD | Director/Board Member | 64 | 18/11/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 401 743 872 | 156 631 424 ( 38,99 %) | 0 | 38,99 % |
Coordinate società
Sichuan Goldstone Asia Pharmaceutical, Inc.
8/F, Area A1 Dadi New Guanghua Plaza
610072, Chengdu
+
http://www.goldstone-group.com![Indirizzo Sichuan Goldstone Asia Pharmaceutical Inc.(300434)](https://cdn.zonebourse.com/static/address/25739805.png)
Settore
Vendite per attività
Vendite per regione
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
-29,84% | 419 Mln | |
+20,78% | 43,29 Mrd | |
+27,64% | 22,38 Mrd | |
+19,25% | 15,51 Mrd | |
+18,68% | 14,52 Mrd | |
+54,64% | 12,93 Mrd | |
-0,05% | 6,79 Mrd | |
-11,39% | 6,56 Mrd | |
+18,33% | 5,87 Mrd | |
-8,87% | 5,73 Mrd |
- Borsa valori
- Azioni
- Azione 300434
- Società Sichuan Goldstone Asia Pharmaceutical Inc.